Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol sulfate tablets for children with 5q spinal muscular atrophy
ChiCTR2000041208Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salbutamol in spinal muscular atrophy (SMA) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Motor function assessment at Month 12. Started Dec 2020; status: recruiting.
02
Drugs
salbutamol
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on ChiCTR2000041208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041208.